Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intracellular Deoxyribonucleic acid (DNA) refers to the genetic material located within the nucleus and mitochondria, as well as pathological DNA fragments found in the cytosol. While nuclear DNA serves as the primary template for genetic inheritance and cellular function, the presence of DNA in the cytoplasm—termed cytosolic DNA—acts as a critical danger-associated molecular pattern (DAMP) that signals cellular stress, damage, or infection (Hopfner & Hornung, 2020). This cytosolic DNA is recognized by innate immune sensors, most notably cyclic GMP-AMP synthase (cGAS), which activates the STING pathway to induce a robust Type I interferon response (Chen et al., 2016). In oncology, intracellular DNA is the direct target of many conventional chemotherapeutic agents, including platinum compounds and anthracyclines, which disrupt DNA integrity to arrest the cell cycle and induce apoptosis (Pommier et al., 2016). However, the aberrant accumulation of self-DNA in the cytosol is a key driver of autoimmune conditions such as systemic lupus erythematosus and Aicardi-Goutières syndrome, making the modulation of DNA sensing and degradation a significant therapeutic strategy (Pisetsky, 2016).
Intracellular DNA is targeted by drugs that induce structural damage, such as alkylation, cross-linking, or intercalation, leading to the inhibition of DNA replication and transcription (Pommier et al., 2016). Additionally, the presence of DNA in the cytosol triggers the cGAS-STING pathway, which serves as a mechanism for enhancing anti-tumor immunity or driving inflammatory pathology (Hopfner & Hornung, 2020).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intracellular Deoxyribonucleic acid (DNA) (DNA).